Dashboard
Manage Tickers

CASI CASI Pharmaceuticals, Inc (DE)

Nasdaq casipharmaceuticals.com


$ 1.76 $ 0.04 (2.35 %)    

Friday, 17-Oct-2025 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.74
$ 1.69
$ 1.61 x 82
$ 2.00 x 1,000
$ 1.68 - $ 1.78
$ 1.09 - $ 6.50
10,299
na
23.42M
$ 0.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2022 09-30-2022 10-Q
2 08-12-2022 06-30-2022 10-Q
3 05-12-2022 03-31-2022 10-Q
4 03-28-2022 12-31-2021 10-K
5 11-12-2021 09-30-2021 10-Q
6 08-12-2021 06-30-2021 10-Q
7 05-13-2021 03-31-2021 10-Q
8 03-30-2021 12-31-2020 10-K
9 11-09-2020 09-30-2020 10-Q
10 08-10-2020 06-30-2020 10-Q
11 05-11-2020 03-31-2020 10-Q
12 03-16-2020 12-31-2019 10-K
13 11-12-2019 09-30-2019 10-Q
14 08-09-2019 06-30-2019 10-Q
15 05-15-2019 03-31-2019 10-Q
16 03-29-2019 12-31-2018 10-K
17 11-14-2018 09-30-2018 10-Q
18 08-14-2018 06-30-2018 10-Q
19 05-15-2018 03-31-2018 10-Q
20 03-29-2018 12-31-2017 10-K
21 11-14-2017 09-30-2017 10-Q
22 08-14-2017 06-30-2017 10-Q
23 05-15-2017 03-31-2017 10-Q
24 03-31-2017 12-31-2016 10-K
25 11-14-2016 09-30-2016 10-Q
26 08-15-2016 06-30-2016 10-Q
27 05-13-2016 03-31-2016 10-Q
28 03-28-2016 12-31-2015 10-K
29 11-13-2015 09-30-2015 10-Q
30 08-14-2015 06-30-2015 10-Q
31 05-15-2015 03-31-2015 10-Q
32 03-27-2015 12-31-2014 10-K
33 11-14-2014 09-30-2014 10-Q
34 08-14-2014 06-30-2014 10-Q
35 05-15-2014 03-31-2014 10-Q
36 03-21-2014 12-31-2013 10-K
37 11-14-2013 09-30-2013 10-Q
38 08-14-2013 06-30-2013 10-Q
39 05-15-2013 03-31-2013 10-Q
40 03-21-2013 12-31-2012 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
10/13/2025 21:06:47

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/26/2025 17:05:59

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

casi-pharmaceuticals-advances-anti-cd38-antibody-cid-103-to-next-dose-cohort-in-phase-1-itp-trial
CASI Pharmaceuticals Advances Anti-CD38 An...
09/08/2025 13:14:07

- CID-103 is a potential best-in-class, clinical stage anti-CD38 monoclonal antibody- Safety profile observed in first four dos...

hc-wainwright--co-reiterates-buy-on-casi-pharmaceuticals-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on CASI...
09/03/2025 11:00:40

HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $4 price tar...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/29/2025 21:06:12

casi-pharmaceuticals-q2-eps-086-misses-047-estimate-sales-4175m-miss-6300m-estimate
CASI Pharmaceuticals Q2 EPS $(0.86) Misses...
08/29/2025 20:08:17

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/18/2025 12:08:41

why-dayforce-shares-are-trading-higher-by-around-21-here-are-20-stocks-moving-premarket
Why Dayforce Shares Are Trading Higher By ...
08/18/2025 10:51:23

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/15/2025 21:22:47

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
08/04/2025 17:06:36

casi-pharmaceuticals-announces-fda-clearance-of-its-ind-application-for-cid-103
CASI Pharmaceuticals Announces FDA Clearan...
08/04/2025 13:00:47

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 21:05:58

casi-pharmaceuticals-appoints-david-cory-as-ceo
CASI Pharmaceuticals Appoints David Cory A...
07/21/2025 20:06:53

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 21:06:13

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 12:08:47

hc-wainwright--co-reiterates-buy-on-casi-pharmaceuticals-maintains-4-price-target
HC Wainwright & Co. Reiterates Buy on CASI...
05/19/2025 10:43:39

HC Wainwright & Co. analyst Sean Lee reiterates CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and maintains $4 price tar...

casi-pharmaceuticals-q1-eps-069-misses-061-estimate-sales-624m-beat-610m-estimate
CASI Pharmaceuticals Q1 EPS $(0.69) Misses...
05/16/2025 22:06:09

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate o...

casi-pharmaceuticals-receives-nasdaq-non-compliance-notice-on-market-value-requirement
CASI Pharmaceuticals Receives Nasdaq Non-C...
05/07/2025 12:06:33

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical co...

hc-wainwright--co-maintains-buy-on-casi-pharmaceuticals-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on CASI ...
04/09/2025 11:20:18

HC Wainwright & Co. analyst Sean Lee maintains CASI Pharmaceuticals (NASDAQ:CASI) with a Buy and lowers the price target...

casi-pharmaceuticals-receives-updated-20m-proposal-from-ceo-dr-wei-wu-he-to-acquire-cos-business-operations-in-china-and-asian-rights-to-certain-pipeline-products-with-special-committee-continuing-evaluation-of-the-proposed-transaction-and-strategic-alternatives
CASI Pharmaceuticals Receives Updated $20M...
04/03/2025 12:17:06

CASI Pharmaceuticals, Inc. (NASDAQ:CASI, ", CASI", ))), a Cayman incorporated biopharmaceutical company focused on deve...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION